(Q37630561)

21 August 2017

title

Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

21 August 2017

1 reference

1 reference

1 reference

1 reference

Franca Fruzzetti

1

1 reference

21 August 2017

Daria Perini

2

1 reference

21 August 2017

Veronica Lazzarini

3

1 reference

21 August 2017

Donatella Parrini

4

1 reference

21 August 2017

Andrea R Genazzani

5

1 reference

21 August 2017

publication date

1 May 2009

1 reference

Gynecological Endocrinology

21 August 2017

published in

1 reference

21 August 2017

volume

25

1 reference

21 August 2017

issue

5

1 reference

21 August 2017

page(s)

335-343

1 reference

The prevalence and features of the polycystic ovary syndrome in an unselected population

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Hypertriglyceridemia, insulin resistance, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Prospective analysis of the insulin-resistance syndrome (syndrome X).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Screening women with polycystic ovary syndrome for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Polycystic ovary syndrome: early detection in the adolescent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Clinical review: Identifying children at risk for polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Obesity and the metabolic syndrome in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Pathophysiology and types of dyslipidemia in PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802630146

10.1080/09513590802630146

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference